Madrigal Pharmaceuticals, Inc.: Form 8-K, filed Jul 22, 2025
Filed with the SEC on Jul 22, 2025 and accepted by EDGAR at Jul 22, 2025, 08:29 ET.
Items reported
- Item 1.01 Entry into a material agreement
- Item 1.02 Termination of a material agreement
- Item 2.03 New direct financial obligation
- Item 7.01 Regulation FD disclosure
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001628280-25-035506. Last ingested by Listed: Oct 24, 2026, 15:05 ET. Listed shows no prices and gives no investment advice.